Business Context and Reporting Period
This Form 6-K filing by Youxin Technology Ltd covers the month of September 2025. The report details the completion of a public offering of units consisting of Class A Ordinary Shares and warrants, executed through an underwriting agreement with Aegis Capital Corp.
Key Financial Metrics
- Net Proceeds: Approximately $5.0 million received after deducting underwriting discounts, commissions, and estimated offering expenses.
- Offering Price: $0.28 per Unit.
- Units Sold: 21,428,571 Units initially, plus partial over-allotment exercise.
- Revenue/Profit/Cash Flow: The filing text does not provide a clear value for operating revenue, net profit, operating cash flow, or margins as this is a transactional filing rather than a periodic financial report.
- Debt/Liquidity: Specific debt levels and liquidity ratios are not disclosed in this text.
Material Changes and Transaction Details
The primary material change is the capital raise via the public offering closed on September 8, 2025. Key transaction components include:
- Unit Composition: Each Unit contains one Class A Share, one Series A Warrant (exercise price $0.28, 5-year term), and one Series B Warrant (exercise price $0.00001, no expiration).
- Over-Allotment: The underwriter partially exercised the option on September 5, 2025, purchasing an additional 3,214,286 Series A Warrants and 3,214,286 Series B Warrants.
- Warrant Adjustments: Complex reset mechanisms exist for Series A Warrants based on the lowest VWAP and a "Floor Price" tied to Nasdaq minimum listing requirements, with periodic adjustments every six months.
Guidance, Outlook, and Risks
- Use of Proceeds: The Company intends to use the net proceeds for general corporate and working capital purposes.
- Risks and Contingencies: The filing notes that the Underwriting Agreement includes customary indemnification obligations and termination provisions. The warrant terms include significant dilution risks due to the low exercise price of Series B Warrants and the reset features of Series A Warrants.
- Management Commentary: No specific forward-looking guidance on revenue or earnings was provided in this text.
Investor Verification Checklist
- Verify the exact number of shares issued upon the partial exercise of the over-allotment option (the text specifies warrants were purchased, but share issuance details for the over-allotment portion require checking the full prospectus).
- Review the full text of the Series A and Series B Warrants (Exhibits 4.1 and 4.2) to understand the specific dilution impact of the "Floor Price" and VWAP reset mechanisms.
- Confirm the Company's current cash position and working capital needs to assess the sufficiency of the $5.0 million net proceeds.
- Check subsequent filings for the actual closing date confirmation and final share count registered on Form F-1.